The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

April 16, 2024

KENTUCKY GOVERNOR SIGNS PBM LAW FOR COMMERCIAL MARKET, STATE EMPLOYEE PLANS 

Kentucky Gov. Andy Beshear (D) signed SB 188 into law. The enrolled law requires PBMs to provide pharmacy reimbursement in the commercial market and in most state employee plans an amount of National Average Drug Acquisition Cost (NADAC) plus a professional dispensing fee effective Jan. 1, 2025. The dispensing fee will be $10.64 until Jan. 1, 2027. The Office of the Insurance Commissioner and the Board of Pharmacy will collaborate to conduct a cost-of-dispensing survey every two years to determine the dispensing fee, with the first survey result effective Jan. 1, 2027. The legislation also addresses network adequacy, limiting the role of mail order pharmacy and ensuring patient access to pharmacies within either 30 miles or a 30-minute drive from the patient’s residence. SB 188 also prohibits PBMs from: charging fees and other reimbursement reductions, including those made retroactively; and from providing lower reimbursement to non-PBM owned or affiliated pharmacies. SB 188 also limits what drugs PBMs can deem “specialty.”

[SB 188 (Enrolled). Kentucky General Assembly. Signed by Governor 4 April 2024.]